Chlorthalidone for High Blood Pressure (DCP Trial)

"Hydrochlorothiazide received a safety rating of 3 from our team at Power. This is due to the fact that it is a Phase 3 trial, which means there is both data supporting its efficacy as well as multiple rounds of data affirming its safety."

"Hydrochlorothiazide is most often used to address edema, but it can also help patients who have suffered a cerebrovascular accident or have kidney diseases. This medication can also be taken preventatively before certain therapeutic procedures."

"Hydrochlorothiazide was originally researched in 2015 at UT Southwestern Medical Center. So far, 276 clinical trials have completed and there are 16 more ongoing studies. A significant amount of these investigations are taking place in Indianapolis, Indiana."

"63 clinical sites are participating in this trial, which include locations in major cities such as Indianapolis, North Chicago and Birmingham. However, there are also many other opportunities to participate at smaller medical centres. Keep in mind that if you decide to take part in this study, it may be more convenient to choose a location near you to avoid extensive travel."

"Patient recruitment for this trial has concluded. The study was first posted on June 15th, 2016 and updated April 21st, 2022. There are 784 other trials related to hypertension currently accepting patients as well as 16 clinical trials testing Hydrochlorothiazide that have open enrollment."

"As of April 21st, 2022, this clinical trial is no longer looking for new patients to enroll. The study was first posted on June 15th, 2016. If you are interested in other studies, 784 trials for hypertension and 16 for Hydrochlorothiazide are still recruiting participants."